新的一周无新事

Briefing.com

Contributor:
Briefing.com
Visit: Briefing.com

By:

Chief Market Analyst

您浏览新闻网站、阅读报纸或观看电视新闻时都无法避开美国新冠疫情,报道聚焦于(为遏制疫情)暂停重启经济或再次发布限制命令,以及无处不在的不确定性。

正如我们无数次被告知的那样,股市讨厌不确定性。因此,如果我们将今早的股市表现作为指引,我们可以说股市确信疫情的不确定性将会消失。

继周五现货市场大涨后,标普500指数期货上涨21点,交易价格高于公允价值0.8%,纳斯达克100指数期货上涨99点,交易价格高于公允价值1.0%,道琼斯工业平均指数期货上涨182点,交易价格高于公允价值0.8%。

故事的逻辑大体相同。

上周五,市场受到吉利德科学公司公布消息的提振,该公司公布了其冠状病毒治疗药物瑞德西韦更多积极的临床数据。今天,市场对辉瑞和BioNTech合作研发的两个新冠候选疫苗获得FDA快速试验批准而兴奋不已。

上周五,花旗集团和高盛分别上调了亚马逊和奈飞的目标价。今天科恩公司将亚马逊的目标价上调至全华尔街最高的3700美元(由该公司此前给出的2750美元上调),Wedbush将苹果公司的目标价从此前的425美元上调至450美元。

上周五美国单日新增确诊病例创新高。疫情的趋势今天仍未改变,不过今天的市场交易趋势并未改变,这种情况是基于一种信念:冠状病毒的治疗方法和/或疫苗可能会在接下来的六个月内出现,并且绝大多数冠状病毒患者可以痊愈。

部分人可能同意或不同意这一观点,但是这是为何确诊病例增加而股市没有崩溃的简洁理由。

今天早上其他支撑市场的因素源于市场并购活动等消息,包括AnalogDevices以210亿美元收购MaximIntegrated Products,高盛给予迪士尼公司买入评级,以及百事公司的公布的第二季度财报好于预期。

第二季度财报季将于本周正式揭幕。银行板块将是本周财报的重点,摩根大通、花旗集团与富国银行将于周二开盘前公布财报。

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from Briefing.com and is being posted with permission from Briefing.com. The views expressed in this material are solely those of the author and/or Briefing.com and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.

Disclosure: Futures Trading

Futures are not suitable for all investors. The amount you may lose may be greater than your initial investment. Before trading futures, please read the CFTC Risk Disclosure. A copy and additional information are available at ibkr.com.

Disclosure: Chinese Translation

这篇文章已被翻译成中文。如英文版本和中文版本之间有任何不一致,以英文版本为准。该文章中的分析仅为提供信息,不是也不应该被视为推销或招揽购买任何证券。文章中讨论的一般市场活动、行业或领域趋势、或其它基于广泛的经济或政治条件的内容,不应被解释为研究结果或投资建议。讨论中提及包括的特定证券、商品、货币、或其它产品均不构成IB推荐购买,出售或持有此类投资的建议。本材料不是也不意图针对个别客户的特定财务条件、投资目标或要求。在根据本材料采取行动之前,您应该考虑是否适合您的具体情况,并在必要时寻求专业建议。

盈透交易员睿智中提供的内容(包括文章和评论)仅作为资讯用途。发布的内容并不代表盈透证券建议您或您的客户联系独立顾问或对冲基金以期获取其服务或投资其产品,也不代表建议您联系在盈透交易员睿智发布文章或向顾问、对冲基金投资的相关人士。在盈透交易员睿智中发布文章的顾问、对冲基金或其他分析师均独立于盈透证券,盈透证券不会对这些顾问、对冲基金或其他人士的过往或将来表现,或其提供的信息之准确性做出任何声明或担保。盈透证券不会进行“适宜性评估”来确保顾问、对冲基金或其他参与方的交易适合于您。

发布内容中提及的证券或其他金融产品并非适合所有投资者。发布的内容并未从您的投资目标、财务状况或需求出发,并不旨在向您推荐任何证券、金融产品或策略。过往业绩并不代表将来表现,如有需要,请咨询相关人士获取专业的建议。

盈透或其分支机构的雇员所发布的任何信息均基于公认的真实可信的信息。然而,盈透或其分支机构无法保证信息的完整性、准确性和适当性。盈透不对任何金融产品其过去或将来的表现作出任何声明或担保。交易员睿智中发布的文章并不代表盈透认为任何特定金融产品或交易策略适合您。